TIFFANI BARTOLAC: Open Payments
NPI 1427087857 · EDGEWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 18 payments from 6 companies in 2025. Trend: 2023 $274 · 2024 $263 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $102 |
| PFIZER INC. | 4 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
Products named: LEQVIO, JARDIANCE, ELIQUIS, VYNDAQEL, Kerendia, FARXIGA, UPTRAVI.
Industry payments across KY — which companies pay providers there.
